Exploration of potential inhibitors for tuberculosis via structure-based drug design, molecular docking, and molecular dynamics simulation studies. - Sreerama Rajasekhar; Ramanathan Karuppasamy; Kaushik Chanda (J. Comput. Chem., 2021)

Identification of novel inhibitors for Prp protein of Mycobacterium tuberculosis by structure based drug design, and molecular dynamics simulations. - Sreerama Rajasekhar; Soumyadip Das; Ramanathan Karuppasamy; Balamurali Musuvathi Motilal; Kaushik Chanda (J. Comput. Chem., 2022)

Streptomyces sp. VITGV156 secondary metabolite binds pathogenic protein PBP2a and Beta-lactamase. - Veilumuthu Pattapulavar; Sathiyabama Ramanujam; Manisha Shah; Muthukumar Thirunavukkarasu; Sivakumar Arumugam; Ramanathan Karuppasamy; Antony V. Samrot; Deepasree K; Subhashree Venugopal; John Godwin Christopher (Frontiers Bioinform., 2025)